Patent · US Active

Pyrro[1,2-b]pyridazinone intermediates

US7842838B2 · kind B2 · utility

0Cited by
2References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 21, 2009
Grant dateNov 30, 2010
Priority date—
Expiry dateAug 21, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is directed to pyrro[1,2-b]pyridazinone compounds and pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.